Kissei Pharmaceutical Co Ltd
TSE:4547
Kissei Pharmaceutical Co Ltd
Accounts Receivables
Kissei Pharmaceutical Co Ltd
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kissei Pharmaceutical Co Ltd
TSE:4547
|
Accounts Receivables
¥28.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Accounts Receivables
¥668.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Accounts Receivables
¥454.2B
|
CAGR 3-Years
25%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Accounts Receivables
¥469.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Accounts Receivables
¥239.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Astellas Pharma Inc
TSE:4503
|
Accounts Receivables
¥535B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
See Also
What is Kissei Pharmaceutical Co Ltd's Accounts Receivables?
Accounts Receivables
28.7B
JPY
Based on the financial report for Mar 31, 2024, Kissei Pharmaceutical Co Ltd's Accounts Receivables amounts to 28.7B JPY.
What is Kissei Pharmaceutical Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
2%
Over the last year, the Accounts Receivables growth was 26%. The average annual Accounts Receivables growth rates for Kissei Pharmaceutical Co Ltd have been 8% over the past three years , 1% over the past five years , and 2% over the past ten years .